Caffeine and Sport Climbing Performance (Climbing&CAF)

April 30, 2026 updated by: Alberto Pérez-López, University of Alcala

Caffeine Ingestion at Acute and Moderate Doses Does Not Improve Sport Climbing Performance: Results From a Randomized Controlled Trial.

To determine the effects of ingesting caffeine at a dose of 3 mg/kg body mass on pull-up performance and handgrip-related measures in trained climbers.

Study Overview

Detailed Description

Introduction: Caffeine is widely recognized as a performance-enhancing substance across numerous athletic disciplines; however, its role in sport climbing has received comparatively limited scientific attention. Because climbing performance relies heavily on grip force, explosive upper-body strength, and localized muscular endurance, this investigation evaluated the short-term impact of a low caffeine dose on climbing-relevant performance outcomes.

Objective: To determine the effects of ingesting caffeine at a dose of 3 mg/kg body mass on pull-up performance and handgrip-related measures in trained climbers.

Methods: Thirteen trained young male climbers participated in a triple-blind, randomized, crossover study design, completing two experimental conditions (caffeine and placebo). Performance assessments included a pull-up one-repetition maximum (1RM), a pull-up power test conducted at multiple external loads, a pull-up endurance test, and several grip performance evaluations, namely maximal dead-hang duration, maximal dead-hang force, and rate of force development (RFD).

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Alcalá de Henares, Madrid, Spain, 28805
        • Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  • Healthy individuals
  • Age between 18 and 40 years
  • At least three months of continuous climbing practice
  • Ability to hang for at least 5 seconds from an 18-mm edge
  • Ability to perform at least one strict body-weight pull-up

Exclusion criteria:

  • Any musculoskeletal or medical condition preventing completion of the experimental protocol
  • Participation in less than three training sessions per week or a total training volume <150 min/week
  • Use of medications or dietary supplements known to affect caffeine metabolism

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
0 mg/kg of caffeine
Placebo supplementation was provide to young male climbers.
Experimental: Caffeine
3 mg/kg of caffeine
Caffeine supplementation was provide to young male climbers.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pull-up 1RM
Time Frame: Through study completion, an average of 4 weeks
Through study completion, an average of 4 weeks
Pull-up strength and power test 1
Time Frame: Through study completion, an average of 4 weeks
Mean and peak velocity will be recorded at 60%, 80%, 90%, 95% and 100% 1RM.
Through study completion, an average of 4 weeks
Pull-up strength and power test 2
Time Frame: Through study completion, an average of 4 weeks
Mean and peak power will be recorded at 60%, 80%, 90%, 95% and 100%1RM.
Through study completion, an average of 4 weeks
Pull-up muscular endurance test
Time Frame: Through study completion, an average of 4 weeks
Using body mass and perform one set of many repetitions as possible until task failure. The total number of repetitions, Vmean, Vpeak, Wmean and Wpeak were recorded.
Through study completion, an average of 4 weeks
Grip endurance in dead-hang.
Time Frame: Through study completion, an average of 4 weeks
Maximum hanging time (MHT) test at an 18-mm edge depth with each hand
Through study completion, an average of 4 weeks
Maximum grip strength in dead-hang
Time Frame: Through study completion, an average of 4 weeks
using the Strength Test (ST), which measures the maximal external load a participant can sustain for 5 seconds while hanging from an 18-mm edge
Through study completion, an average of 4 weeks
Grip rate of force development (RFD).
Time Frame: Through study completion, an average of 4 weeks
measuring the maximal one-hand pull (voluntary contraction) at an 18 mm edge with a force sensor
Through study completion, an average of 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition
Time Frame: Through study completion, an average of 4 weeks
Using bioelectrical impedance
Through study completion, an average of 4 weeks
Dietary habits
Time Frame: Through study completion, an average of 4 weeks
24 h dietary recall
Through study completion, an average of 4 weeks
Mood states
Time Frame: Through study completion, an average of 4 weeks
Using the Profile of Mood States (POMS) on a 0-4 scale.
Through study completion, an average of 4 weeks
Physical activity habits
Time Frame: Through study completion, an average of 4 weeks
International Physical Activity Questionnaire (IPAQ). Report the unabbreviated scale title. Scores are typically expressed as MET-minutes/week or by activity categories (low, moderate, high), depending on the scoring protocol used. There is no fixed universal minimum or maximum score for MET-minutes/week, as scores depend on reported activity levels. Higher scores indicate better outcomes (greater physical activity).
Through study completion, an average of 4 weeks
Rate of perceived exertion
Time Frame: Through study completion, an average of 4 weeks
Using Rating of Perceived Exertion (RPE). Category Ratio 10 (CR10) Scale: minimum 0, maximum 10 (or 11 if including "maximal"). Higher scores indicate worse outcomes (greater perceived exertion).
Through study completion, an average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alberto Pérez López, PhD, University of Alcala

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2025

Primary Completion (Actual)

March 30, 2025

Study Completion (Actual)

October 30, 2025

Study Registration Dates

First Submitted

December 15, 2025

First Submitted That Met QC Criteria

December 31, 2025

First Posted (Actual)

January 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 6, 2026

Last Update Submitted That Met QC Criteria

April 30, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • CEIP/2024/5/117 (Other Identifier: CEIP/2024/5/117)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caffeine

Clinical Trials on Placebo

Subscribe